Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PR Test ApS
APS
Dissolved
CVR 42165107
Strandvejen 49
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2021
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK 22K
-80% vs 2021
EBITDA margin
100.0%
-80% vs 2021
Equity ratio
96.7%
Financial strength
Net profit 2022
DKK 13K
-84% vs 2021
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
DKK 22K
-80%
EBITDA
DKK 22K
-80%
Net profit
DKK 13K
-84%
Total assets
DKK 140K
-50%
Equity
DKK 135K
+11%
Employees
—
—
Company information
Legal name
PR Test ApS
CVR number
42165107
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. februar 2021
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Contact
Address
Strandvejen 49
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Odense
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
Income statement
DKK thousands
Item
2021
2022
Revenue
106
22
Staff expenses
-0
-0
EBITDA
106
22
Depreciation & amort.
-0
-0
EBIT
106
22
Net financials
-1
-4
Profit before tax
105
18
Tax
23
5
Net profit
82
13
Balance sheet
DKK thousands
Item
2021
2022
Total assets
282
140
Equity
122
135
Long-term debt
0
0
Short-term debt
160
5
Total debt
160
5
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2021
2022
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
2021
2022
Return on equity
9.9%
This company
18.4%
Market median
-46% vs market
2021
2022
Net profit margin
61.6%
This company
8.1%
Market median
+660% vs market
2021
2022
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
2021
2022
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2021
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-02-25 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
RS
Rex Sander Jakobsen
Chief Executive Officer
Chief Executive Officer
2021
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
REX HOLDING ApS
Company
50.0%
50.0%
2021
PP Holding Odense ApS
Company
50.0%
50.0%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of PR Test ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Rex Sander Jakobsen
Chief Executive Officer
0 companies